Gavi Leap
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn more
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn moreGavi's five-year plan
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Latest news
View allEthiopia has launched the national introduction of the HepB BD vaccine, marking a major step in strengthening newborn immunization and combating the transmission of Hepatitis B virus.
Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million. Savings expected to help secure 30 million additional doses, protecting up to 7 million more children with malaria vaccine.
Pakistan launches nationwide measles-rubella vaccination campaign to protect 34 million children
The Government of Pakistan’s FDI – in partnership with Gavi, UNICEF, and the WHO – launched a national measles and rubella (MR) vaccination campaign in Islamabad today to protect 34.6 million children.
What is VaccinesWork?
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn more
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn moreVaccinesWork latest
Mauritania now offers the six-in-one childhood vaccine. Here’s why that matters
It sounds like a small step, but it’s anything but: in July, Mauritania swapped out the five-in-one “pentavalent” vaccine for the hexavalent jab.
Winning against measles: five charts that tell a remarkable 24-year story
A new report shows remarkable gains against measles since 2000, yet significant challenges persist.
Long COVID’s hidden toll: the South Africans still battling fatigue, anxiety and memory loss
Long COVID isn’t purely a biological problem; it’s a human one, shaped by both physiology and lived experience.
